Envoy Medical Inc Asset Turnover Ratio (COCH), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Envoy Medical Inc   (NASDAQ: COCH)
 

Envoy Medical Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Envoy Medical Inc 's asset turnover ratio, the ratio that measures the ability of Envoy Medical Inc 's assets to generate revenue, sequentially decreased to 0.01 in the second quarter (Jun 30 2026), which does not come as a surprise, as the Envoy Medical Inc continue to experience difficult business climate.

Within sector 160 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2633 to 2829.

Asset Turnover Ratio Definition



COCH Asset Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Asset Change 186.74 % 187.16 % 17.78 % -12.34 % 46.95 %
Y / Y Revenue Change -34.62 % -15.22 % 78.57 % -25 % 14.71 %
Asset Turnover Ratio (TTM) 0.01 0.02 0.02 0.02 0.02
COCH's Total Ranking # 2829 # 2633 # 3546 # 2877 #
Seq. Asset Change -4.81 % 119.46 % 66.1 % -17.36 % -4.67 %
Seq. Revenue Change 30.77 % -48 % 78.57 % -46.15 % 69.57 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 161
Healthcare Sector # 446
Overall Market # 2829

Asset Turnover Ratio Statistics
High Average Low
4.29 1.95 0.6
(Mar 31 2026)   (Sep 30 2024)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Bioxcel Therapeutics Inc   0.02 $ 0.742  Millions$ 38.133  Millions
Hyperion Defi inc   0.02 $ 1.401  Millions$ 79.440  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Ataibeckley Inc   0.02 $ 4.473  Millions$ 265.553  Millions
Seres Therapeutics Inc   0.02 $ 1.883  Millions$ 125.218  Millions
Alumis inc   0.01 $ 7.398  Millions$ 533.040  Millions
Vyne Therapeutics Inc   0.01 $ 0.430  Millions$ 31.089  Millions
Anteris Technologies Global Corp   0.01 $ 2.242  Millions$ 166.751  Millions
Entrada Therapeutics Inc   0.01 $ 4.686  Millions$ 356.168  Millions
Prime Medicine Inc   0.01 $ 4.073  Millions$ 317.879  Millions
Vivosim Labs Inc   0.01 $ 0.112  Millions$ 8.892  Millions
Pulse Biosciences Inc   0.01 $ 1.185  Millions$ 100.122  Millions
Envoy Medical Inc   0.01 $ 0.207  Millions$ 17.628  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 1.809  Millions$ 171.835  Millions
Eyepoint Inc   0.01 $ 2.788  Millions$ 283.025  Millions
Cardiff Oncology Inc   0.01 $ 0.508  Millions$ 53.041  Millions
Newamsterdam Pharma Company N v   0.01 $ 7.121  Millions$ 748.202  Millions
Upstream Bio Inc   0.01 $ 3.158  Millions$ 336.048  Millions
Clene Inc   0.01 $ 0.197  Millions$ 21.287  Millions
Scienture Holdings Inc   0.01 $ 0.821  Millions$ 89.351  Millions
Sharps Technology Inc   0.01 $ 1.960  Millions$ 263.597  Millions
Absci Corp  0.01 $ 1.561  Millions$ 231.450  Millions
Cg Oncology Inc   0.01 $ 6.228  Millions$ 935.606  Millions
Aclarion Inc   0.01 $ 0.084  Millions$ 16.388  Millions
Lightwave Logic Inc 0.00 $ 0.250  Millions$ 79.491  Millions
Pavmed Inc 0.00 $ 0.126  Millions$ 40.629  Millions
Prokidney Corp 0.00 $ 0.818  Millions$ 307.246  Millions
IMPACT BIOMEDICAL INC. 0.00 $ 0.035  Millions$ 17.361  Millions
Cardio Diagnostics Holdings Inc 0.00 $ 0.014  Millions$ 8.510  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.